Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Ultragenyx Pharmaceutical Inc. buy Truist Financial Co.

Ultragenyx Pharmaceutical Inc.
Start price
€27.80
05.11.25 / 50%
Target price
€78.31
05.11.26
Performance (%)
-21.04%
Price
?
08:33
Summary
This prediction is currently active. The price of Ultragenyx Pharmaceutical Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -21.04%. This prediction currently runs until 05.11.26. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Ultragenyx Pharmaceutical Inc. 9.794% 9.794%
iShares Core DAX® -1,59 % 5,03 %
iShares Nasdaq 100 -4,15 % -0,13 %
iShares Nikkei 225® -6,30 % 0,53 %
iShares S&P 500 -3,23 % 0,47 %

Comments by Truist_Financial_Co_ for this prediction

In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Prediction Buy
Perf. (%) -21.04%
Target price 78.309
Change
Ends at 05.11.26

Ultragenyx Pharmaceutical (NASDAQ:RARE) had its price target lowered by analysts at Truist Financial Corporation from $100.00 to $90.00. They now have a "buy" rating on the stock.
Ratings data for RARE provided by MarketBeat

Truist Financial Co. 
0
Report Share
05.11.25